Procedures & recovery · patient guide

TAVR vs surgical aortic valve replacement: what the difference means

TAVR and surgical aortic valve replacement both treat a narrowed aortic valve, but they replace it by different routes. TAVR delivers a replacement valve through a catheter, while surgical replacement opens the chest. The real decision is not which method sounds newer; it is which approach the heart team judges suitable for your valve anatomy, heart function, other conditions and preferences.

Go to the practical guidance ↓
AI illustration: A doctor in a white coat consulting with a patient in a blue shirt at a desk with documents and a book.
AI-generated illustration for care planning; not a photograph of a real patient, clinician or hospital, and not a diagnostic image.
In this guide

The core difference: how the new valve reaches the aortic position

In surgical aortic valve replacement, the surgeon opens the chest, connects the patient to a heart-lung machine, removes the diseased valve and sews a replacement valve into place. The replacement may be mechanical or biological. This is a major operation with general anaesthesia and a period of intensive monitoring afterwards.

TAVR, also called TAVI, is a catheter-based procedure. A replacement valve is mounted on a delivery system and advanced to the aortic valve, commonly through an artery in the groin, though other access routes exist. The new valve is positioned inside the diseased valve and expanded. Some TAVR procedures use general anaesthesia; others use lighter sedation or local anaesthesia, depending on the team and the case.

The practical consequence is that TAVR avoids a full chest incision and the heart-lung machine in the standard transfemoral route. That does not make it a minor procedure. It still involves a prosthetic valve inside the heart, access through major blood vessels, and the possibility of serious complications. The heart team's assessment of your anatomy and risk is what determines whether either route is appropriate.

Why the choice is not simply 'newer versus older'

Both approaches are established. Current guidance from major cardiac societies supports TAVR for many patients with severe symptomatic aortic stenosis, and the appropriate choice depends on age, estimated surgical risk, anatomy and other conditions. For some patients, surgery remains the preferred or only suitable route; for others, TAVR is favoured. Some cases are genuinely borderline and need a structured discussion.

A useful way to think about it is that the two procedures solve the same problem through different trade-offs. Surgery offers direct visualisation of the valve and the chance to address other cardiac problems during the same operation, such as coronary bypass grafting. TAVR offers a less invasive route but depends on suitable access vessels and valve anatomy, and it carries its own procedural risks, including stroke, vascular injury, bleeding, paravalvular leak and the need for a permanent pacemaker in some patients.

The heart team should explain which trade-offs matter in your case. Ask them to state the reasoning, not just the recommendation.

What the heart team needs to know before recommending either route

Aortic stenosis is diagnosed and graded with echocardiography, and the decision about intervention depends on whether the stenosis is severe and whether symptoms or heart function changes are attributable to it. The team will also want to understand your other medical conditions, your current medicines, your kidney function, your lung function and your frailty or functional status.

For TAVR specifically, the anatomy of the aortic valve and the access vessels matters. CT imaging of the chest, abdomen and pelvis is commonly used to assess the valve, the aorta and the iliofemoral arteries. The team also considers the distance from the access site to the valve and whether the vessels can safely accommodate the delivery system.

For surgery, the team considers the operative risk, the condition of the coronary arteries, other valve disease and whether concomitant procedures are needed. Neither route is decided from a single scan. The assessment is a synthesis, and the treating clinicians are responsible for it.

  • Ask which findings in your imaging and tests drove the recommendation.
  • Ask whether your case was discussed by a multidisciplinary heart team and what alternatives were considered.
  • Ask what would change the recommendation, such as a new symptom, a change in kidney function or a different access route.

Recovery and follow-up differ in pace and shape, not in a fixed timetable

After surgical replacement, patients typically spend time in intensive care and then a hospital ward, with a period of wound healing and gradual return to activity. After TAVR, many patients are mobilised sooner and spend less time in intensive care, but this varies with the access route, anaesthesia, complications and the hospital's own protocols. No single recovery timeline applies to everyone, and you should ask the treating team what to expect in your case rather than relying on general figures.

Both routes require follow-up. A biological valve, whether surgical or transcatheter, can degenerate over time, and follow-up echocardiography is used to monitor function. Mechanical valves require lifelong anticoagulation, which carries its own risks and monitoring needs. Antiplatelet or anticoagulant medicine after TAVR is decided by the treating team and depends on other conditions and medicines.

Ask how follow-up will be arranged after you return home, who will review your imaging, and what symptoms should prompt urgent local assessment.

What this means for planning care in China

If you are considering aortic valve intervention in China, the first practical step is to establish whether your records are sufficient for a meaningful review. That generally means recent echocardiography reports, any cardiac CT or catheterisation reports, a list of your medicines and doses, and a summary of your symptoms and other conditions. The receiving hospital decides whether it can assess you and whether either procedure is suitable; an enquiry or records review does not establish that.

Ask the hospital directly which procedure it proposes, why, and what its written plan and fee scope include. Published reference ranges for heart valve procedures are indicative only, are not a fixed quote, and do not tell you whether TAVR or surgery is the right choice for you. The final price requires an individual assessment and written confirmation of the treatment plan and fee scope. Hospital fees, our coordination fees and travel costs are separate, and the hospital's written quote is the document that settles what is covered.

For general orientation, the TAVR and TAVI reference page and the heart valve replacement page describe the procedures; the cardiac surgery specialty page explains the broader service context. These pages complement, rather than replace, the clinical assessment.

Related treatment reference

Questions to bring to the consultation

A productive consultation is one where you leave knowing what the team recommends, what evidence supports it and what remains uncertain. You do not need to decide between TAVR and surgery before the appointment; you need enough information to judge whether the recommendation fits your situation.

Ask about the severity of your stenosis and whether intervention is indicated now. Ask which procedure the team proposes and what specific findings support it. Ask about the main risks in your case, including stroke, bleeding, vascular injury, pacemaker need and paravalvular leak, and how the team plans to manage them. Ask what the alternatives are and what happens if you choose to wait. Ask about follow-up, medicines and when you can return to normal activity.

If you are travelling to China, ask how records should be shared, what language support is available and what the hospital's written plan includes. An initial enquiry through ChinaSpecialistCare is free and can help identify missing information and the relevant next step; it is not a diagnosis or a promise of acceptance. A proxy consultation is optional, not a prerequisite for every appointment.

Sources & scope of this guide

References and official service information relevant to this guide.

  1. Related treatment reference
  2. Heart valve replacement - NHS
  3. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidel

This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.